IP Verse

C-Met Modulator Pharmaceutical Compositions

Patent No. EP2593090 (titled "C-Met Modulator Pharmaceutical Compositions") was filed by Exelixis on Jul 18, 2011. The application was issued on Oct 13, 2021.

Patent Summary

Patent Family

Patent family tree
Statuses, jurisdictions and citation links are shared on request.

Patent Oppositions (3)

Patent oppositions filed by competitors challenge the validity of a granted patent. These oppositions are typically based on claims of prior art, lack of novelty, or non-obviousness. They are a key part of the process for determining a patent's strength and enforceability.

CompanyOpposition DateRepresentative
GENERICS UKJul 13, 2022TER MEER STEINMEISTER & PARTNER GBR
STADA ARZNEIMITTELJul 12, 2022HAMM&WITTKOPP PATENTANWÄLTE PARTMBB
TEVA PHARMACEUTICAL INDUSTRIES LTDJul 12, 2022D YOUNG

Dossier Documents

The dossier documents provide a comprehensive record of the patent's prosecution history - including filings, correspondence, and decisions made by patent offices - and are crucial for understanding the patent's legal journey and any challenges it may have faced during examination.

  • Date

    Description

EP2593090

EXELIXIS
Application Number
EP11740764A
Filing Date
Jul 18, 2011
Status
Opposition Rejected
Mar 27, 2026
Publication Date
Oct 13, 2021
External Links
Slate, Register , Google Patents